Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (NASDAQ: KNSA) last traded at $79.03, up 0.71% on the session. The quote above updates while this page is open; the figures below are drawn from Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares’s own filings and are restated only when a new one is published.
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares trades on NASDAQ under the ticker KNSA. Its market capitalisation is $6.51 billion.
Valuation measures for Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $6.51B |
|---|---|
| Enterprise value | $6.54B |
| P/E ratio | 86.85 |
| Price / sales | 8.64 |
| Price / book | 10.75 |
| Beta | 0.21 |
Trailing-twelve-month figures tagged in Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $754.04M |
|---|---|
| Net income (TTM) | $73.06M |
| EPS (TTM) | $0.910 |
| Operating margin | 12.36% |
| Return on equity | 12.06% |
| Cash | $189.95M |
Range and volume for KNSA over the past 52 weeks.
| 52-week high | $82.94 |
|---|---|
| 52-week low | $32.89 |
| Volume | 252.2K |
| Average volume | 749.1K |
| Previous close | $78.47 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.